EPSM de la Somme
Dury, 80480, France
Location status: Recruiting
NCT Number: NCT07540429
Impaired social cognition and cognitive control associated with borderline personality disorder (BPD) remain less explored. Recent Franco-Canadian study, has shown the feasibility of a neuroimaging tests in Quebec adolescents with BPD. This study aims to increase knowledgements related to neural correlates of BPD and clinical disorders.
Interested in participating?
Request Info12 year–17 year
Female
Interventional
Not applicable
Dury, 80480, France
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Investigators used fMRI to compare patterns of regional brain activation between three groups of adolescents girls: Six female adolescents meeting criteria for BPD, 6 female adolescents meeting criteria of ADHD and 6 female adolescents without psychiatric disorder were recruited.
Time frame: 2 years
Establishment of activation maps by statistical analysis of local signal variations to locate functional regions essential to motor skills and language.
Time frame: 2 years
Pilot feasibility study with a small sample size
Contact information is provided by the study sponsor or research team.
Jean Marc GUILE, Professor
CONTACT
MICHAEL MONET, PhD
CONTACT
Etablissement Public de la Sante Mentale de la Somme
Network
Feasibility Study Using Functional Magnetic Resonance Imaging (fMRI) on Bordeline Personality Disorders in Adolescents
Acronym: ADO IMAGE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06880640
Borderline Personality Disorder, Borderline Personality Disorder (BPD)
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07337889
Bipolar Disorder, Bipolar Disorder (BD)
Montpellier, France
View Trial DetailsNCT07639957
Behavior, Borderline Personality Disorder
Heidelberg, Germany
View Trial DetailsNCT06446765
Borderline Personality Disorder, Mental Disorders
New Haven, Connecticut, United States
View Trial Details